Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
IL12B VHH recombinant monoclonal antibody
IL13 VHH recombinant monoclonal antibody
IL13RA1 VHH recombinant monoclonal antibody
IL15 VHH recombinant monoclonal antibody
IL17A VHH recombinant monoclonal antibody
IL17RA VHH recombinant monoclonal antibody
IL18 VHH recombinant monoclonal antibody
IL1A VHH recombinant monoclonal antibody
IL1B VHH recombinant monoclonal antibody
IL1RAP VHH recombinant monoclonal antibody
IL1RL1 VHH recombinant monoclonal antibody
IL20 VHH recombinant monoclonal antibody